Prudent Man Advisors, LLC Bristol Myers Squibb CO Transaction History
Prudent Man Advisors, LLC
- $263 Million
- Q3 2025
A detailed history of Prudent Man Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Prudent Man Advisors, LLC holds 7,141 shares of BMY stock, worth $334,270. This represents 0.12% of its overall portfolio holdings.
Number of Shares
7,141
Previous 12,303
41.96%
Holding current value
$334,270
Previous $569,000
43.41%
% of portfolio
0.12%
Previous 0.19%
Shares
13 transactions
Others Institutions Holding BMY
# of Institutions
2,680Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...